Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.2.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GW.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GW.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.2.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.2.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.14.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-13753.9France
BF.7.14.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.14.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.14.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.13.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HL.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HL.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HL.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HL.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.42.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.42.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.42.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.42.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DZ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DZ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DZ.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DZ.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.14.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-13753.9France
BF.7.14.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.14.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.14.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DY.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used